Human Gene Therapy Market, Global Outlook and Forecast 2022-2028
Gene therapy is a medical approach that treats or prevents disease by correcting the underlying genetic problem. Gene therapy techniques allow doctors to treat a disorder by altering a person's genetic makeup instead of using drugs or surgery.
This report contains market size and forecasts of Human Gene Therapy in global, including the following market information:
Global Human Gene Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Gene Therapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Gene Therapy companies in 2021 (%)
The global Human Gene Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non-viral Vectors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Gene Therapy include Biogen, Sarepta Therapeutics, Gilead Sciences, Amgen, Novartis, Orchard Therapeutics, Spark Therapeutics, Agc Biologics and Anges, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Gene Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Gene Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Gene Therapy Market Segment Percentages, by Type, 2021 (%)
Global Human Gene Therapy Market Segment Percentages, by Application, 2021 (%)
Global Human Gene Therapy Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Human Gene Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Gene Therapy revenues share in global market, 2021 (%)
Key companies Human Gene Therapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Gene Therapy sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Human Gene Therapy in global, including the following market information:
Global Human Gene Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Gene Therapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Gene Therapy companies in 2021 (%)
The global Human Gene Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non-viral Vectors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Gene Therapy include Biogen, Sarepta Therapeutics, Gilead Sciences, Amgen, Novartis, Orchard Therapeutics, Spark Therapeutics, Agc Biologics and Anges, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Gene Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Gene Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Gene Therapy Market Segment Percentages, by Type, 2021 (%)
- Non-viral Vectors
- Viral Vectors
Global Human Gene Therapy Market Segment Percentages, by Application, 2021 (%)
- Neurological Diseases
- Cancer
- DMD (Duchenne Muscular Dystrophy)
- Hepatological Diseases
- Others
Global Human Gene Therapy Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Human Gene Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Gene Therapy revenues share in global market, 2021 (%)
Key companies Human Gene Therapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Gene Therapy sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Biogen
- Sarepta Therapeutics
- Gilead Sciences
- Amgen
- Novartis
- Orchard Therapeutics
- Spark Therapeutics
- Agc Biologics
- Anges
- Bluebird Bio
- Jazz Pharmaceuticals
- Dynavax Technologies
- Human Stem Cells Institute
- Sibiono Genetech
- Shanghai Sunway Biotech
- Uniqure N.V.
- Gensight Biologics S.A.
- Celgene Corporation
- Cellectis
- Sangamo Therapeutics
- Mustang Bio
- AGTC
- Poseida Therapeutics
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Human Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HUMAN GENE THERAPY OVERALL MARKET SIZE
2.1 Global Human Gene Therapy Market Size: 2021 VS 2028
2.2 Global Human Gene Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Gene Therapy Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Human Gene Therapy Players in Global Market
3.2 Top Global Human Gene Therapy Companies Ranked by Revenue
3.3 Global Human Gene Therapy Revenue by Companies
3.4 Global Human Gene Therapy Sales by Companies
3.5 Global Human Gene Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Gene Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Gene Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Gene Therapy Players in Global Market
3.8.1 List of Global Tier 1 Human Gene Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Gene Therapy Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Human Gene Therapy Market Size Markets, 2021 & 2028
4.1.2 Non-viral Vectors
4.1.3 Viral Vectors
4.2 By Type - Global Human Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Human Gene Therapy Revenue, 2017-2022
4.2.2 By Type - Global Human Gene Therapy Revenue, 2023-2028
4.2.3 By Type - Global Human Gene Therapy Revenue Market Share, 2017-2028
4.3 By Type - Global Human Gene Therapy Sales & Forecasts
4.3.1 By Type - Global Human Gene Therapy Sales, 2017-2022
4.3.2 By Type - Global Human Gene Therapy Sales, 2023-2028
4.3.3 By Type - Global Human Gene Therapy Sales Market Share, 2017-2028
4.4 By Type - Global Human Gene Therapy Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Human Gene Therapy Market Size, 2021 & 2028
5.1.2 Neurological Diseases
5.1.3 Cancer
5.1.4 DMD (Duchenne Muscular Dystrophy)
5.1.5 Hepatological Diseases
5.1.6 Others
5.2 By Application - Global Human Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Human Gene Therapy Revenue, 2017-2022
5.2.2 By Application - Global Human Gene Therapy Revenue, 2023-2028
5.2.3 By Application - Global Human Gene Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global Human Gene Therapy Sales & Forecasts
5.3.1 By Application - Global Human Gene Therapy Sales, 2017-2022
5.3.2 By Application - Global Human Gene Therapy Sales, 2023-2028
5.3.3 By Application - Global Human Gene Therapy Sales Market Share, 2017-2028
5.4 By Application - Global Human Gene Therapy Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Human Gene Therapy Market Size, 2021 & 2028
6.2 By Region - Global Human Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Human Gene Therapy Revenue, 2017-2022
6.2.2 By Region - Global Human Gene Therapy Revenue, 2023-2028
6.2.3 By Region - Global Human Gene Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global Human Gene Therapy Sales & Forecasts
6.3.1 By Region - Global Human Gene Therapy Sales, 2017-2022
6.3.2 By Region - Global Human Gene Therapy Sales, 2023-2028
6.3.3 By Region - Global Human Gene Therapy Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Human Gene Therapy Revenue, 2017-2028
6.4.2 By Country - North America Human Gene Therapy Sales, 2017-2028
6.4.3 US Human Gene Therapy Market Size, 2017-2028
6.4.4 Canada Human Gene Therapy Market Size, 2017-2028
6.4.5 Mexico Human Gene Therapy Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Human Gene Therapy Revenue, 2017-2028
6.5.2 By Country - Europe Human Gene Therapy Sales, 2017-2028
6.5.3 Germany Human Gene Therapy Market Size, 2017-2028
6.5.4 France Human Gene Therapy Market Size, 2017-2028
6.5.5 U.K. Human Gene Therapy Market Size, 2017-2028
6.5.6 Italy Human Gene Therapy Market Size, 2017-2028
6.5.7 Russia Human Gene Therapy Market Size, 2017-2028
6.5.8 Nordic Countries Human Gene Therapy Market Size, 2017-2028
6.5.9 Benelux Human Gene Therapy Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Human Gene Therapy Revenue, 2017-2028
6.6.2 By Region - Asia Human Gene Therapy Sales, 2017-2028
6.6.3 China Human Gene Therapy Market Size, 2017-2028
6.6.4 Japan Human Gene Therapy Market Size, 2017-2028
6.6.5 South Korea Human Gene Therapy Market Size, 2017-2028
6.6.6 Southeast Asia Human Gene Therapy Market Size, 2017-2028
6.6.7 India Human Gene Therapy Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Human Gene Therapy Revenue, 2017-2028
6.7.2 By Country - South America Human Gene Therapy Sales, 2017-2028
6.7.3 Brazil Human Gene Therapy Market Size, 2017-2028
6.7.4 Argentina Human Gene Therapy Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Gene Therapy Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Human Gene Therapy Sales, 2017-2028
6.8.3 Turkey Human Gene Therapy Market Size, 2017-2028
6.8.4 Israel Human Gene Therapy Market Size, 2017-2028
6.8.5 Saudi Arabia Human Gene Therapy Market Size, 2017-2028
6.8.6 UAE Human Gene Therapy Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Biogen
7.1.1 Biogen Corporate Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Human Gene Therapy Major Product Offerings
7.1.4 Biogen Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.1.5 Biogen Key News
7.2 Sarepta Therapeutics
7.2.1 Sarepta Therapeutics Corporate Summary
7.2.2 Sarepta Therapeutics Business Overview
7.2.3 Sarepta Therapeutics Human Gene Therapy Major Product Offerings
7.2.4 Sarepta Therapeutics Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.2.5 Sarepta Therapeutics Key News
7.3 Gilead Sciences
7.3.1 Gilead Sciences Corporate Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Human Gene Therapy Major Product Offerings
7.3.4 Gilead Sciences Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.3.5 Gilead Sciences Key News
7.4 Amgen
7.4.1 Amgen Corporate Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Human Gene Therapy Major Product Offerings
7.4.4 Amgen Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.4.5 Amgen Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Human Gene Therapy Major Product Offerings
7.5.4 Novartis Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.5.5 Novartis Key News
7.6 Orchard Therapeutics
7.6.1 Orchard Therapeutics Corporate Summary
7.6.2 Orchard Therapeutics Business Overview
7.6.3 Orchard Therapeutics Human Gene Therapy Major Product Offerings
7.6.4 Orchard Therapeutics Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.6.5 Orchard Therapeutics Key News
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Corporate Summary
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Human Gene Therapy Major Product Offerings
7.7.4 Spark Therapeutics Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.7.5 Spark Therapeutics Key News
7.8 Agc Biologics
7.8.1 Agc Biologics Corporate Summary
7.8.2 Agc Biologics Business Overview
7.8.3 Agc Biologics Human Gene Therapy Major Product Offerings
7.8.4 Agc Biologics Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.8.5 Agc Biologics Key News
7.9 Anges
7.9.1 Anges Corporate Summary
7.9.2 Anges Business Overview
7.9.3 Anges Human Gene Therapy Major Product Offerings
7.9.4 Anges Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.9.5 Anges Key News
7.10 Bluebird Bio
7.10.1 Bluebird Bio Corporate Summary
7.10.2 Bluebird Bio Business Overview
7.10.3 Bluebird Bio Human Gene Therapy Major Product Offerings
7.10.4 Bluebird Bio Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.10.5 Bluebird Bio Key News
7.11 Jazz Pharmaceuticals
7.11.1 Jazz Pharmaceuticals Corporate Summary
7.11.2 Jazz Pharmaceuticals Human Gene Therapy Business Overview
7.11.3 Jazz Pharmaceuticals Human Gene Therapy Major Product Offerings
7.11.4 Jazz Pharmaceuticals Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.11.5 Jazz Pharmaceuticals Key News
7.12 Dynavax Technologies
7.12.1 Dynavax Technologies Corporate Summary
7.12.2 Dynavax Technologies Human Gene Therapy Business Overview
7.12.3 Dynavax Technologies Human Gene Therapy Major Product Offerings
7.12.4 Dynavax Technologies Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.12.5 Dynavax Technologies Key News
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Corporate Summary
7.13.2 Human Stem Cells Institute Human Gene Therapy Business Overview
7.13.3 Human Stem Cells Institute Human Gene Therapy Major Product Offerings
7.13.4 Human Stem Cells Institute Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.13.5 Human Stem Cells Institute Key News
7.14 Sibiono Genetech
7.14.1 Sibiono Genetech Corporate Summary
7.14.2 Sibiono Genetech Business Overview
7.14.3 Sibiono Genetech Human Gene Therapy Major Product Offerings
7.14.4 Sibiono Genetech Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.14.5 Sibiono Genetech Key News
7.15 Shanghai Sunway Biotech
7.15.1 Shanghai Sunway Biotech Corporate Summary
7.15.2 Shanghai Sunway Biotech Business Overview
7.15.3 Shanghai Sunway Biotech Human Gene Therapy Major Product Offerings
7.15.4 Shanghai Sunway Biotech Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.15.5 Shanghai Sunway Biotech Key News
7.16 Uniqure N.V.
7.16.1 Uniqure N.V. Corporate Summary
7.16.2 Uniqure N.V. Business Overview
7.16.3 Uniqure N.V. Human Gene Therapy Major Product Offerings
7.16.4 Uniqure N.V. Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.16.5 Uniqure N.V. Key News
7.17 Gensight Biologics S.A.
7.17.1 Gensight Biologics S.A. Corporate Summary
7.17.2 Gensight Biologics S.A. Business Overview
7.17.3 Gensight Biologics S.A. Human Gene Therapy Major Product Offerings
7.17.4 Gensight Biologics S.A. Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.17.5 Gensight Biologics S.A. Key News
7.18 Celgene Corporation
7.18.1 Celgene Corporation Corporate Summary
7.18.2 Celgene Corporation Business Overview
7.18.3 Celgene Corporation Human Gene Therapy Major Product Offerings
7.18.4 Celgene Corporation Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.18.5 Celgene Corporation Key News
7.19 Cellectis
7.19.1 Cellectis Corporate Summary
7.19.2 Cellectis Business Overview
7.19.3 Cellectis Human Gene Therapy Major Product Offerings
7.19.4 Cellectis Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.19.5 Cellectis Key News
7.20 Sangamo Therapeutics
7.20.1 Sangamo Therapeutics Corporate Summary
7.20.2 Sangamo Therapeutics Business Overview
7.20.3 Sangamo Therapeutics Human Gene Therapy Major Product Offerings
7.20.4 Sangamo Therapeutics Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.20.5 Sangamo Therapeutics Key News
7.21 Mustang Bio
7.21.1 Mustang Bio Corporate Summary
7.21.2 Mustang Bio Business Overview
7.21.3 Mustang Bio Human Gene Therapy Major Product Offerings
7.21.4 Mustang Bio Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.21.5 Mustang Bio Key News
7.22 AGTC
7.22.1 AGTC Corporate Summary
7.22.2 AGTC Business Overview
7.22.3 AGTC Human Gene Therapy Major Product Offerings
7.22.4 AGTC Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.22.5 AGTC Key News
7.23 Poseida Therapeutics
7.23.1 Poseida Therapeutics Corporate Summary
7.23.2 Poseida Therapeutics Business Overview
7.23.3 Poseida Therapeutics Human Gene Therapy Major Product Offerings
7.23.4 Poseida Therapeutics Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.23.5 Poseida Therapeutics Key News
8 GLOBAL HUMAN GENE THERAPY PRODUCTION CAPACITY, ANALYSIS
8.1 Global Human Gene Therapy Production Capacity, 2017-2028
8.2 Human Gene Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Gene Therapy Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HUMAN GENE THERAPY SUPPLY CHAIN ANALYSIS
10.1 Human Gene Therapy Industry Value Chain
10.2 Human Gene Therapy Upstream Market
10.3 Human Gene Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Gene Therapy Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Human Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HUMAN GENE THERAPY OVERALL MARKET SIZE
2.1 Global Human Gene Therapy Market Size: 2021 VS 2028
2.2 Global Human Gene Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Gene Therapy Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Human Gene Therapy Players in Global Market
3.2 Top Global Human Gene Therapy Companies Ranked by Revenue
3.3 Global Human Gene Therapy Revenue by Companies
3.4 Global Human Gene Therapy Sales by Companies
3.5 Global Human Gene Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Gene Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Gene Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Gene Therapy Players in Global Market
3.8.1 List of Global Tier 1 Human Gene Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Gene Therapy Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Human Gene Therapy Market Size Markets, 2021 & 2028
4.1.2 Non-viral Vectors
4.1.3 Viral Vectors
4.2 By Type - Global Human Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Human Gene Therapy Revenue, 2017-2022
4.2.2 By Type - Global Human Gene Therapy Revenue, 2023-2028
4.2.3 By Type - Global Human Gene Therapy Revenue Market Share, 2017-2028
4.3 By Type - Global Human Gene Therapy Sales & Forecasts
4.3.1 By Type - Global Human Gene Therapy Sales, 2017-2022
4.3.2 By Type - Global Human Gene Therapy Sales, 2023-2028
4.3.3 By Type - Global Human Gene Therapy Sales Market Share, 2017-2028
4.4 By Type - Global Human Gene Therapy Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Human Gene Therapy Market Size, 2021 & 2028
5.1.2 Neurological Diseases
5.1.3 Cancer
5.1.4 DMD (Duchenne Muscular Dystrophy)
5.1.5 Hepatological Diseases
5.1.6 Others
5.2 By Application - Global Human Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Human Gene Therapy Revenue, 2017-2022
5.2.2 By Application - Global Human Gene Therapy Revenue, 2023-2028
5.2.3 By Application - Global Human Gene Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global Human Gene Therapy Sales & Forecasts
5.3.1 By Application - Global Human Gene Therapy Sales, 2017-2022
5.3.2 By Application - Global Human Gene Therapy Sales, 2023-2028
5.3.3 By Application - Global Human Gene Therapy Sales Market Share, 2017-2028
5.4 By Application - Global Human Gene Therapy Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Human Gene Therapy Market Size, 2021 & 2028
6.2 By Region - Global Human Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Human Gene Therapy Revenue, 2017-2022
6.2.2 By Region - Global Human Gene Therapy Revenue, 2023-2028
6.2.3 By Region - Global Human Gene Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global Human Gene Therapy Sales & Forecasts
6.3.1 By Region - Global Human Gene Therapy Sales, 2017-2022
6.3.2 By Region - Global Human Gene Therapy Sales, 2023-2028
6.3.3 By Region - Global Human Gene Therapy Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Human Gene Therapy Revenue, 2017-2028
6.4.2 By Country - North America Human Gene Therapy Sales, 2017-2028
6.4.3 US Human Gene Therapy Market Size, 2017-2028
6.4.4 Canada Human Gene Therapy Market Size, 2017-2028
6.4.5 Mexico Human Gene Therapy Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Human Gene Therapy Revenue, 2017-2028
6.5.2 By Country - Europe Human Gene Therapy Sales, 2017-2028
6.5.3 Germany Human Gene Therapy Market Size, 2017-2028
6.5.4 France Human Gene Therapy Market Size, 2017-2028
6.5.5 U.K. Human Gene Therapy Market Size, 2017-2028
6.5.6 Italy Human Gene Therapy Market Size, 2017-2028
6.5.7 Russia Human Gene Therapy Market Size, 2017-2028
6.5.8 Nordic Countries Human Gene Therapy Market Size, 2017-2028
6.5.9 Benelux Human Gene Therapy Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Human Gene Therapy Revenue, 2017-2028
6.6.2 By Region - Asia Human Gene Therapy Sales, 2017-2028
6.6.3 China Human Gene Therapy Market Size, 2017-2028
6.6.4 Japan Human Gene Therapy Market Size, 2017-2028
6.6.5 South Korea Human Gene Therapy Market Size, 2017-2028
6.6.6 Southeast Asia Human Gene Therapy Market Size, 2017-2028
6.6.7 India Human Gene Therapy Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Human Gene Therapy Revenue, 2017-2028
6.7.2 By Country - South America Human Gene Therapy Sales, 2017-2028
6.7.3 Brazil Human Gene Therapy Market Size, 2017-2028
6.7.4 Argentina Human Gene Therapy Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Gene Therapy Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Human Gene Therapy Sales, 2017-2028
6.8.3 Turkey Human Gene Therapy Market Size, 2017-2028
6.8.4 Israel Human Gene Therapy Market Size, 2017-2028
6.8.5 Saudi Arabia Human Gene Therapy Market Size, 2017-2028
6.8.6 UAE Human Gene Therapy Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Biogen
7.1.1 Biogen Corporate Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Human Gene Therapy Major Product Offerings
7.1.4 Biogen Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.1.5 Biogen Key News
7.2 Sarepta Therapeutics
7.2.1 Sarepta Therapeutics Corporate Summary
7.2.2 Sarepta Therapeutics Business Overview
7.2.3 Sarepta Therapeutics Human Gene Therapy Major Product Offerings
7.2.4 Sarepta Therapeutics Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.2.5 Sarepta Therapeutics Key News
7.3 Gilead Sciences
7.3.1 Gilead Sciences Corporate Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Human Gene Therapy Major Product Offerings
7.3.4 Gilead Sciences Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.3.5 Gilead Sciences Key News
7.4 Amgen
7.4.1 Amgen Corporate Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Human Gene Therapy Major Product Offerings
7.4.4 Amgen Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.4.5 Amgen Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Human Gene Therapy Major Product Offerings
7.5.4 Novartis Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.5.5 Novartis Key News
7.6 Orchard Therapeutics
7.6.1 Orchard Therapeutics Corporate Summary
7.6.2 Orchard Therapeutics Business Overview
7.6.3 Orchard Therapeutics Human Gene Therapy Major Product Offerings
7.6.4 Orchard Therapeutics Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.6.5 Orchard Therapeutics Key News
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Corporate Summary
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Human Gene Therapy Major Product Offerings
7.7.4 Spark Therapeutics Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.7.5 Spark Therapeutics Key News
7.8 Agc Biologics
7.8.1 Agc Biologics Corporate Summary
7.8.2 Agc Biologics Business Overview
7.8.3 Agc Biologics Human Gene Therapy Major Product Offerings
7.8.4 Agc Biologics Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.8.5 Agc Biologics Key News
7.9 Anges
7.9.1 Anges Corporate Summary
7.9.2 Anges Business Overview
7.9.3 Anges Human Gene Therapy Major Product Offerings
7.9.4 Anges Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.9.5 Anges Key News
7.10 Bluebird Bio
7.10.1 Bluebird Bio Corporate Summary
7.10.2 Bluebird Bio Business Overview
7.10.3 Bluebird Bio Human Gene Therapy Major Product Offerings
7.10.4 Bluebird Bio Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.10.5 Bluebird Bio Key News
7.11 Jazz Pharmaceuticals
7.11.1 Jazz Pharmaceuticals Corporate Summary
7.11.2 Jazz Pharmaceuticals Human Gene Therapy Business Overview
7.11.3 Jazz Pharmaceuticals Human Gene Therapy Major Product Offerings
7.11.4 Jazz Pharmaceuticals Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.11.5 Jazz Pharmaceuticals Key News
7.12 Dynavax Technologies
7.12.1 Dynavax Technologies Corporate Summary
7.12.2 Dynavax Technologies Human Gene Therapy Business Overview
7.12.3 Dynavax Technologies Human Gene Therapy Major Product Offerings
7.12.4 Dynavax Technologies Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.12.5 Dynavax Technologies Key News
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Corporate Summary
7.13.2 Human Stem Cells Institute Human Gene Therapy Business Overview
7.13.3 Human Stem Cells Institute Human Gene Therapy Major Product Offerings
7.13.4 Human Stem Cells Institute Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.13.5 Human Stem Cells Institute Key News
7.14 Sibiono Genetech
7.14.1 Sibiono Genetech Corporate Summary
7.14.2 Sibiono Genetech Business Overview
7.14.3 Sibiono Genetech Human Gene Therapy Major Product Offerings
7.14.4 Sibiono Genetech Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.14.5 Sibiono Genetech Key News
7.15 Shanghai Sunway Biotech
7.15.1 Shanghai Sunway Biotech Corporate Summary
7.15.2 Shanghai Sunway Biotech Business Overview
7.15.3 Shanghai Sunway Biotech Human Gene Therapy Major Product Offerings
7.15.4 Shanghai Sunway Biotech Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.15.5 Shanghai Sunway Biotech Key News
7.16 Uniqure N.V.
7.16.1 Uniqure N.V. Corporate Summary
7.16.2 Uniqure N.V. Business Overview
7.16.3 Uniqure N.V. Human Gene Therapy Major Product Offerings
7.16.4 Uniqure N.V. Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.16.5 Uniqure N.V. Key News
7.17 Gensight Biologics S.A.
7.17.1 Gensight Biologics S.A. Corporate Summary
7.17.2 Gensight Biologics S.A. Business Overview
7.17.3 Gensight Biologics S.A. Human Gene Therapy Major Product Offerings
7.17.4 Gensight Biologics S.A. Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.17.5 Gensight Biologics S.A. Key News
7.18 Celgene Corporation
7.18.1 Celgene Corporation Corporate Summary
7.18.2 Celgene Corporation Business Overview
7.18.3 Celgene Corporation Human Gene Therapy Major Product Offerings
7.18.4 Celgene Corporation Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.18.5 Celgene Corporation Key News
7.19 Cellectis
7.19.1 Cellectis Corporate Summary
7.19.2 Cellectis Business Overview
7.19.3 Cellectis Human Gene Therapy Major Product Offerings
7.19.4 Cellectis Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.19.5 Cellectis Key News
7.20 Sangamo Therapeutics
7.20.1 Sangamo Therapeutics Corporate Summary
7.20.2 Sangamo Therapeutics Business Overview
7.20.3 Sangamo Therapeutics Human Gene Therapy Major Product Offerings
7.20.4 Sangamo Therapeutics Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.20.5 Sangamo Therapeutics Key News
7.21 Mustang Bio
7.21.1 Mustang Bio Corporate Summary
7.21.2 Mustang Bio Business Overview
7.21.3 Mustang Bio Human Gene Therapy Major Product Offerings
7.21.4 Mustang Bio Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.21.5 Mustang Bio Key News
7.22 AGTC
7.22.1 AGTC Corporate Summary
7.22.2 AGTC Business Overview
7.22.3 AGTC Human Gene Therapy Major Product Offerings
7.22.4 AGTC Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.22.5 AGTC Key News
7.23 Poseida Therapeutics
7.23.1 Poseida Therapeutics Corporate Summary
7.23.2 Poseida Therapeutics Business Overview
7.23.3 Poseida Therapeutics Human Gene Therapy Major Product Offerings
7.23.4 Poseida Therapeutics Human Gene Therapy Sales and Revenue in Global (2017-2022)
7.23.5 Poseida Therapeutics Key News
8 GLOBAL HUMAN GENE THERAPY PRODUCTION CAPACITY, ANALYSIS
8.1 Global Human Gene Therapy Production Capacity, 2017-2028
8.2 Human Gene Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Gene Therapy Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HUMAN GENE THERAPY SUPPLY CHAIN ANALYSIS
10.1 Human Gene Therapy Industry Value Chain
10.2 Human Gene Therapy Upstream Market
10.3 Human Gene Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Gene Therapy Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Human Gene Therapy in Global Market
Table 2. Top Human Gene Therapy Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Human Gene Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Human Gene Therapy Revenue Share by Companies, 2017-2022
Table 5. Global Human Gene Therapy Sales by Companies, (K Units), 2017-2022
Table 6. Global Human Gene Therapy Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Human Gene Therapy Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Human Gene Therapy Product Type
Table 9. List of Global Tier 1 Human Gene Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Gene Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Gene Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Human Gene Therapy Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Human Gene Therapy Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Human Gene Therapy Sales (K Units), 2017-2022
Table 15. By Type - Global Human Gene Therapy Sales (K Units), 2023-2028
Table 16. By Application – Global Human Gene Therapy Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Human Gene Therapy Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Human Gene Therapy Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Human Gene Therapy Sales (K Units), 2017-2022
Table 20. By Application - Global Human Gene Therapy Sales (K Units), 2023-2028
Table 21. By Region – Global Human Gene Therapy Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Human Gene Therapy Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Human Gene Therapy Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Human Gene Therapy Sales (K Units), 2017-2022
Table 25. By Region - Global Human Gene Therapy Sales (K Units), 2023-2028
Table 26. By Country - North America Human Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Human Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Human Gene Therapy Sales, (K Units), 2017-2022
Table 29. By Country - North America Human Gene Therapy Sales, (K Units), 2023-2028
Table 30. By Country - Europe Human Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Human Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Human Gene Therapy Sales, (K Units), 2017-2022
Table 33. By Country - Europe Human Gene Therapy Sales, (K Units), 2023-2028
Table 34. By Region - Asia Human Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Human Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Human Gene Therapy Sales, (K Units), 2017-2022
Table 37. By Region - Asia Human Gene Therapy Sales, (K Units), 2023-2028
Table 38. By Country - South America Human Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Human Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Human Gene Therapy Sales, (K Units), 2017-2022
Table 41. By Country - South America Human Gene Therapy Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Human Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Human Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Human Gene Therapy Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Human Gene Therapy Sales, (K Units), 2023-2028
Table 46. Biogen Corporate Summary
Table 47. Biogen Human Gene Therapy Product Offerings
Table 48. Biogen Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Sarepta Therapeutics Corporate Summary
Table 50. Sarepta Therapeutics Human Gene Therapy Product Offerings
Table 51. Sarepta Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Gilead Sciences Corporate Summary
Table 53. Gilead Sciences Human Gene Therapy Product Offerings
Table 54. Gilead Sciences Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Amgen Corporate Summary
Table 56. Amgen Human Gene Therapy Product Offerings
Table 57. Amgen Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Novartis Corporate Summary
Table 59. Novartis Human Gene Therapy Product Offerings
Table 60. Novartis Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Orchard Therapeutics Corporate Summary
Table 62. Orchard Therapeutics Human Gene Therapy Product Offerings
Table 63. Orchard Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Spark Therapeutics Corporate Summary
Table 65. Spark Therapeutics Human Gene Therapy Product Offerings
Table 66. Spark Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Agc Biologics Corporate Summary
Table 68. Agc Biologics Human Gene Therapy Product Offerings
Table 69. Agc Biologics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Anges Corporate Summary
Table 71. Anges Human Gene Therapy Product Offerings
Table 72. Anges Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Bluebird Bio Corporate Summary
Table 74. Bluebird Bio Human Gene Therapy Product Offerings
Table 75. Bluebird Bio Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Jazz Pharmaceuticals Corporate Summary
Table 77. Jazz Pharmaceuticals Human Gene Therapy Product Offerings
Table 78. Jazz Pharmaceuticals Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Dynavax Technologies Corporate Summary
Table 80. Dynavax Technologies Human Gene Therapy Product Offerings
Table 81. Dynavax Technologies Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Human Stem Cells Institute Corporate Summary
Table 83. Human Stem Cells Institute Human Gene Therapy Product Offerings
Table 84. Human Stem Cells Institute Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Sibiono Genetech Corporate Summary
Table 86. Sibiono Genetech Human Gene Therapy Product Offerings
Table 87. Sibiono Genetech Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Shanghai Sunway Biotech Corporate Summary
Table 89. Shanghai Sunway Biotech Human Gene Therapy Product Offerings
Table 90. Shanghai Sunway Biotech Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Uniqure N.V. Corporate Summary
Table 92. Uniqure N.V. Human Gene Therapy Product Offerings
Table 93. Uniqure N.V. Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Gensight Biologics S.A. Corporate Summary
Table 95. Gensight Biologics S.A. Human Gene Therapy Product Offerings
Table 96. Gensight Biologics S.A. Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Celgene Corporation Corporate Summary
Table 98. Celgene Corporation Human Gene Therapy Product Offerings
Table 99. Celgene Corporation Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Cellectis Corporate Summary
Table 101. Cellectis Human Gene Therapy Product Offerings
Table 102. Cellectis Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Sangamo Therapeutics Corporate Summary
Table 104. Sangamo Therapeutics Human Gene Therapy Product Offerings
Table 105. Sangamo Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Mustang Bio Corporate Summary
Table 107. Mustang Bio Human Gene Therapy Product Offerings
Table 108. Mustang Bio Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 109. AGTC Corporate Summary
Table 110. AGTC Human Gene Therapy Product Offerings
Table 111. AGTC Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 112. Poseida Therapeutics Corporate Summary
Table 113. Poseida Therapeutics Human Gene Therapy Product Offerings
Table 114. Poseida Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 115. Human Gene Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 116. Global Human Gene Therapy Capacity Market Share of Key Manufacturers, 2020-2022
Table 117. Global Human Gene Therapy Production by Region, 2017-2022 (K Units)
Table 118. Global Human Gene Therapy Production by Region, 2023-2028 (K Units)
Table 119. Human Gene Therapy Market Opportunities & Trends in Global Market
Table 120. Human Gene Therapy Market Drivers in Global Market
Table 121. Human Gene Therapy Market Restraints in Global Market
Table 122. Human Gene Therapy Raw Materials
Table 123. Human Gene Therapy Raw Materials Suppliers in Global Market
Table 124. Typical Human Gene Therapy Downstream
Table 125. Human Gene Therapy Downstream Clients in Global Market
Table 126. Human Gene Therapy Distributors and Sales Agents in Global Market
Table 1. Key Players of Human Gene Therapy in Global Market
Table 2. Top Human Gene Therapy Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Human Gene Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Human Gene Therapy Revenue Share by Companies, 2017-2022
Table 5. Global Human Gene Therapy Sales by Companies, (K Units), 2017-2022
Table 6. Global Human Gene Therapy Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Human Gene Therapy Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Human Gene Therapy Product Type
Table 9. List of Global Tier 1 Human Gene Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Gene Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Gene Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Human Gene Therapy Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Human Gene Therapy Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Human Gene Therapy Sales (K Units), 2017-2022
Table 15. By Type - Global Human Gene Therapy Sales (K Units), 2023-2028
Table 16. By Application – Global Human Gene Therapy Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Human Gene Therapy Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Human Gene Therapy Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Human Gene Therapy Sales (K Units), 2017-2022
Table 20. By Application - Global Human Gene Therapy Sales (K Units), 2023-2028
Table 21. By Region – Global Human Gene Therapy Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Human Gene Therapy Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Human Gene Therapy Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Human Gene Therapy Sales (K Units), 2017-2022
Table 25. By Region - Global Human Gene Therapy Sales (K Units), 2023-2028
Table 26. By Country - North America Human Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Human Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Human Gene Therapy Sales, (K Units), 2017-2022
Table 29. By Country - North America Human Gene Therapy Sales, (K Units), 2023-2028
Table 30. By Country - Europe Human Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Human Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Human Gene Therapy Sales, (K Units), 2017-2022
Table 33. By Country - Europe Human Gene Therapy Sales, (K Units), 2023-2028
Table 34. By Region - Asia Human Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Human Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Human Gene Therapy Sales, (K Units), 2017-2022
Table 37. By Region - Asia Human Gene Therapy Sales, (K Units), 2023-2028
Table 38. By Country - South America Human Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Human Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Human Gene Therapy Sales, (K Units), 2017-2022
Table 41. By Country - South America Human Gene Therapy Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Human Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Human Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Human Gene Therapy Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Human Gene Therapy Sales, (K Units), 2023-2028
Table 46. Biogen Corporate Summary
Table 47. Biogen Human Gene Therapy Product Offerings
Table 48. Biogen Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Sarepta Therapeutics Corporate Summary
Table 50. Sarepta Therapeutics Human Gene Therapy Product Offerings
Table 51. Sarepta Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Gilead Sciences Corporate Summary
Table 53. Gilead Sciences Human Gene Therapy Product Offerings
Table 54. Gilead Sciences Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Amgen Corporate Summary
Table 56. Amgen Human Gene Therapy Product Offerings
Table 57. Amgen Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Novartis Corporate Summary
Table 59. Novartis Human Gene Therapy Product Offerings
Table 60. Novartis Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Orchard Therapeutics Corporate Summary
Table 62. Orchard Therapeutics Human Gene Therapy Product Offerings
Table 63. Orchard Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Spark Therapeutics Corporate Summary
Table 65. Spark Therapeutics Human Gene Therapy Product Offerings
Table 66. Spark Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Agc Biologics Corporate Summary
Table 68. Agc Biologics Human Gene Therapy Product Offerings
Table 69. Agc Biologics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Anges Corporate Summary
Table 71. Anges Human Gene Therapy Product Offerings
Table 72. Anges Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Bluebird Bio Corporate Summary
Table 74. Bluebird Bio Human Gene Therapy Product Offerings
Table 75. Bluebird Bio Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Jazz Pharmaceuticals Corporate Summary
Table 77. Jazz Pharmaceuticals Human Gene Therapy Product Offerings
Table 78. Jazz Pharmaceuticals Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Dynavax Technologies Corporate Summary
Table 80. Dynavax Technologies Human Gene Therapy Product Offerings
Table 81. Dynavax Technologies Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Human Stem Cells Institute Corporate Summary
Table 83. Human Stem Cells Institute Human Gene Therapy Product Offerings
Table 84. Human Stem Cells Institute Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Sibiono Genetech Corporate Summary
Table 86. Sibiono Genetech Human Gene Therapy Product Offerings
Table 87. Sibiono Genetech Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Shanghai Sunway Biotech Corporate Summary
Table 89. Shanghai Sunway Biotech Human Gene Therapy Product Offerings
Table 90. Shanghai Sunway Biotech Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Uniqure N.V. Corporate Summary
Table 92. Uniqure N.V. Human Gene Therapy Product Offerings
Table 93. Uniqure N.V. Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Gensight Biologics S.A. Corporate Summary
Table 95. Gensight Biologics S.A. Human Gene Therapy Product Offerings
Table 96. Gensight Biologics S.A. Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Celgene Corporation Corporate Summary
Table 98. Celgene Corporation Human Gene Therapy Product Offerings
Table 99. Celgene Corporation Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Cellectis Corporate Summary
Table 101. Cellectis Human Gene Therapy Product Offerings
Table 102. Cellectis Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Sangamo Therapeutics Corporate Summary
Table 104. Sangamo Therapeutics Human Gene Therapy Product Offerings
Table 105. Sangamo Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Mustang Bio Corporate Summary
Table 107. Mustang Bio Human Gene Therapy Product Offerings
Table 108. Mustang Bio Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 109. AGTC Corporate Summary
Table 110. AGTC Human Gene Therapy Product Offerings
Table 111. AGTC Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 112. Poseida Therapeutics Corporate Summary
Table 113. Poseida Therapeutics Human Gene Therapy Product Offerings
Table 114. Poseida Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 115. Human Gene Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 116. Global Human Gene Therapy Capacity Market Share of Key Manufacturers, 2020-2022
Table 117. Global Human Gene Therapy Production by Region, 2017-2022 (K Units)
Table 118. Global Human Gene Therapy Production by Region, 2023-2028 (K Units)
Table 119. Human Gene Therapy Market Opportunities & Trends in Global Market
Table 120. Human Gene Therapy Market Drivers in Global Market
Table 121. Human Gene Therapy Market Restraints in Global Market
Table 122. Human Gene Therapy Raw Materials
Table 123. Human Gene Therapy Raw Materials Suppliers in Global Market
Table 124. Typical Human Gene Therapy Downstream
Table 125. Human Gene Therapy Downstream Clients in Global Market
Table 126. Human Gene Therapy Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Human Gene Therapy Segment by Type
Figure 2. Human Gene Therapy Segment by Application
Figure 3. Global Human Gene Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Gene Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Gene Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. Human Gene Therapy Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Gene Therapy Revenue in 2021
Figure 9. By Type - Global Human Gene Therapy Sales Market Share, 2017-2028
Figure 10. By Type - Global Human Gene Therapy Revenue Market Share, 2017-2028
Figure 11. By Type - Global Human Gene Therapy Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Human Gene Therapy Sales Market Share, 2017-2028
Figure 13. By Application - Global Human Gene Therapy Revenue Market Share, 2017-2028
Figure 14. By Application - Global Human Gene Therapy Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Human Gene Therapy Sales Market Share, 2017-2028
Figure 16. By Region - Global Human Gene Therapy Revenue Market Share, 2017-2028
Figure 17. By Country - North America Human Gene Therapy Revenue Market Share, 2017-2028
Figure 18. By Country - North America Human Gene Therapy Sales Market Share, 2017-2028
Figure 19. US Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Human Gene Therapy Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Human Gene Therapy Sales Market Share, 2017-2028
Figure 24. Germany Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. France Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Human Gene Therapy Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Human Gene Therapy Sales Market Share, 2017-2028
Figure 33. China Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. India Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Human Gene Therapy Revenue Market Share, 2017-2028
Figure 39. By Country - South America Human Gene Therapy Sales Market Share, 2017-2028
Figure 40. Brazil Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Human Gene Therapy Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Human Gene Therapy Sales Market Share, 2017-2028
Figure 44. Turkey Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 48. Global Human Gene Therapy Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Human Gene Therapy by Region, 2021 VS 2028
Figure 50. Human Gene Therapy Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Human Gene Therapy Segment by Type
Figure 2. Human Gene Therapy Segment by Application
Figure 3. Global Human Gene Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Gene Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Gene Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. Human Gene Therapy Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Gene Therapy Revenue in 2021
Figure 9. By Type - Global Human Gene Therapy Sales Market Share, 2017-2028
Figure 10. By Type - Global Human Gene Therapy Revenue Market Share, 2017-2028
Figure 11. By Type - Global Human Gene Therapy Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Human Gene Therapy Sales Market Share, 2017-2028
Figure 13. By Application - Global Human Gene Therapy Revenue Market Share, 2017-2028
Figure 14. By Application - Global Human Gene Therapy Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Human Gene Therapy Sales Market Share, 2017-2028
Figure 16. By Region - Global Human Gene Therapy Revenue Market Share, 2017-2028
Figure 17. By Country - North America Human Gene Therapy Revenue Market Share, 2017-2028
Figure 18. By Country - North America Human Gene Therapy Sales Market Share, 2017-2028
Figure 19. US Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Human Gene Therapy Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Human Gene Therapy Sales Market Share, 2017-2028
Figure 24. Germany Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. France Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Human Gene Therapy Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Human Gene Therapy Sales Market Share, 2017-2028
Figure 33. China Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. India Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Human Gene Therapy Revenue Market Share, 2017-2028
Figure 39. By Country - South America Human Gene Therapy Sales Market Share, 2017-2028
Figure 40. Brazil Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Human Gene Therapy Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Human Gene Therapy Sales Market Share, 2017-2028
Figure 44. Turkey Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Human Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 48. Global Human Gene Therapy Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Human Gene Therapy by Region, 2021 VS 2028
Figure 50. Human Gene Therapy Industry Value Chain
Figure 51. Marketing Channels
